Search - tctmd.com

Displaying 301 - 320 of 366

Sort: Relevancy | Date

News Features

Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways

Michael O'Riordan

October 05, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Daily News

不同次复诊时收缩压大幅波动与死亡风险升高相关

Michael O'Riordan

September 27, 2016

News Daily News

Rapid Treatment Remains Key for Thrombectomy in Acute Stroke but Still Works Several Hours After Onset

Todd Neale

September 27, 2016

News Daily News

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Michael O'Riordan

September 27, 2016

News Daily News

Los Grandes Cambios en la Presión Arterial Sistólica de una Visita Médica a Otra se asocian a un Mayor Riesgo de Mortalidad

Michael O'Riordan

September 27, 2016

News Daily News

Large Swings in Visit-to-Visit Systolic Blood Pressure Linked With Increased Risk of Death

Michael O'Riordan

September 27, 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Daily News

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

Michael O'Riordan

September 15, 2016

News Conference News ESC 2016

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Michael O'Riordan

August 28, 2016

News Conference News ESC 2016

Thrombectomy for Stroke in a Cardiology Department: Preliminary Study Explores the Possibilities

Todd Neale

August 27, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Daily News

The Billions Spent on Healthcare for Sedentary Citizens Warrants Global Response

L.A. McKeown

July 28, 2016

News Daily News

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Michael O'Riordan

June 29, 2016

News Daily News

Protein-Based Risk Score Shows Potential for Tailored Medicine in Cardiology

Yael L. Maxwell

June 24, 2016

News Daily News

Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire

Michael O'Riordan

June 24, 2016

News Daily News

Aspiration Thrombectomy: No Benefit in Large Meta-analysis, Although Selective Use Persists

Yael L. Maxwell

May 03, 2016

News Daily News

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

Michael O'Riordan

May 02, 2016

News Conference News ACC 2016

Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding

Todd Neale

April 06, 2016

Advertisement

Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

不同次复诊时收缩压大幅波动与死亡风险升高相关

Rapid Treatment Remains Key for Thrombectomy in Acute Stroke but Still Works Several Hours After Onset

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Los Grandes Cambios en la Presión Arterial Sistólica de una Visita Médica a Otra se asocian a un Mayor Riesgo de Mortalidad

Large Swings in Visit-to-Visit Systolic Blood Pressure Linked With Increased Risk of Death

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Thrombectomy for Stroke in a Cardiology Department: Preliminary Study Explores the Possibilities

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

The Billions Spent on Healthcare for Sedentary Citizens Warrants Global Response

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Protein-Based Risk Score Shows Potential for Tailored Medicine in Cardiology

Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire

Aspiration Thrombectomy: No Benefit in Large Meta-analysis, Although Selective Use Persists

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content